GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Price-to-Operating-Cash-Flow

Medeon Biodesign (ROCO:6499) Price-to-Operating-Cash-Flow : (As of Jun. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Price-to-Operating-Cash-Flow?

As of today (2024-06-21), Medeon Biodesign's share price is NT$49.90. Medeon Biodesign's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-6.26. Hence, Medeon Biodesign's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medeon Biodesign's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, Medeon Biodesign's highest Price-to-Operating-Cash-Flow Ratio was 40.57. The lowest was 14.03. And the median was 19.38.

ROCO:6499's Price-to-Operating-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 20.745
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medeon Biodesign's Cash Flow from Operations per share for the three months ended in Mar. 2024 was NT$-1.90. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$-6.26.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -23.80% per year.

During the past 12 years, Medeon Biodesign's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.30% per year. The lowest was -45.90% per year. And the median was -1.10% per year.


Medeon Biodesign Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medeon Biodesign's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Price-to-Operating-Cash-Flow Chart

Medeon Biodesign Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.49 - - - -

Medeon Biodesign Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medeon Biodesign's Price-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Price-to-Operating-Cash-Flow falls into.



Medeon Biodesign Price-to-Operating-Cash-Flow Calculation

Medeon Biodesign's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=49.90/-6.256
=

Medeon Biodesign's Share Price of today is NT$49.90.
Medeon Biodesign's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-6.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Medeon Biodesign Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medeon Biodesign (ROCO:6499) Business Description

Traded in Other Exchanges
N/A
Address
No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines